PT  - JOURNAL ARTICLE
AU  - Paola Storti
AU  - Valentina Marchica
AU  - Rosanna Vescovini
AU  - Valentina Franceschi
AU  - Luca Russo
AU  - Vincenzo Raimondi
AU  - Denise Toscani
AU  - Jessica Burroughs Garcia
AU  - Federica Costa
AU  - Benedetta Dalla Palma
AU  - Naomi Soressi
AU  - Mariateresa Giaimo
AU  - Nicolas Thomas Iannozzi
AU  - Laura Notarfranchi
AU  - Gabriella Sammarelli
AU  - Gaetano Donofrio
AU  - Nicola Giuliani
TI  - Impact of Omicron variant on the response to SARS-CoV-2 mRNA Vaccination in multiple myeloma
AID  - 10.1101/2022.02.25.22271501
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.02.25.22271501
4099  - http://medrxiv.org/content/early/2022/02/26/2022.02.25.22271501.short
4100  - http://medrxiv.org/content/early/2022/02/26/2022.02.25.22271501.full
AB  - Multiple myeloma (MM) patients may have a reduced response to vaccination due to immunodeficiency. The humoral and cellular response to SARS-CoV-2 mRNA full vaccination and booster dose as well as the impact of spike variants, including the emerging Omicron one, are still unclear and have been investigated in this study in a cohort of MM patients and those with pre-malignant monoclonal gammopathies.Firstly, we have shown that MM patients with relapsed-refractory disease (MMR) had a reduced spike-specific antibody levels and neutralizing titers after SARS-CoV-2 mRNA full vaccination. Interestingly, all the analyzed variants, remarkably Omicron, had a significant negative impact on the neutralizing ability of the vaccine-induced antibodies in all patients with MM and in smoldering MM too. Moreover, lower spike-specific IL-2-producing CD4+ T cells and reduced cytotoxic spike-specific IFN-γ and TNF-α-producing-CD8+ T cells were found in MM patients as compared to MGUS.Finally, we found that booster immunization improved SARS-CoV-2 spike humoral and cellular responses in newly diagnosed MM (MMD) patients and in most, but not all, MMR patients. After the booster dose, a significant increase of the neutralizing antibody titers against almost all the analyzed variants was achieved in MMD. On the other hand, in MMR patients, Omicron retain a negative impact on neutralizing ability, suggesting these patients need to be considered still at risk of Omicron SARS-CoV-2 infection with a clinically relevant disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by funding from: AIRC under IG IG2017 ID. 20299 project and International Myeloma Society (IMS) under Paula and Rodeger Riney Foundation Translational Research Grant (PI Nicola Giuliani) and by the Associazione Italiana contro Leucemie, Linfomi e Mielomi ONLUS, ParmAIL.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Area Vasta Emilia Nord (AVEN) Ethics CommitteeI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors